prednisolone has been researched along with Hepatitis, Chronic in 97 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-one hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA positive Chinese patients with chronic active hepatitis B were randomized to receive either prednisolone or placebo oral for 8 weeks." | 9.07 | A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. ( Lee, SD; Lin, HC; Lo, KJ; Tong, MJ; Tsai, YT; Wu, JC, 1991) |
| "Twenty patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis, who received 40 mg of prednisolone per day for three weeks followed by withdrawal, were studied for changes in alanine aminotransferase (ALT), triiodothyronine (T3), thyroxine (T4), and hepatitis B virus DNA polymerase (HBV-DNAp) levels determined before and during prednisolone treatment and after its withdrawal." | 7.68 | Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. ( Itoh, S; Marutani, K; Matsuo, S; Oda, T; Sasaki, K, 1990) |
| "Short-term prednisolone therapy was instituted on 27 patients with chronic active hepatitis (CAH) type B, in an attempt to induce seroconversion from hepatitis B e antigen (HBeAg) to the corresponding antibody (anti-HBe)." | 7.67 | Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. ( Ikeda, K; Kojima, M; Kumada, H; Mayumi, M; Seto, S; Suzuki, H; Tsukada, T; Yoshida, A, 1987) |
| "In 1981, we initiated combination therapy of short-term prednisolone withdrawal and adenine arabinoside (ARA-A) or interferon (IF) for the treatment of chronic hepatitis B." | 7.67 | Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. ( Omata, M; Uchiumi, K, 1986) |
| "In 42 patients with chronic active hepatitis (CAH), liver biopsies were subjected to histological study and morphometry before and after prednisolone treatment (21 patients comprising group I) and treatment with a complex of vitamins B1, B6, B12 and C (21 patients comprising group II)." | 6.66 | [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens]. ( Mansurov, KhKh; Mirodzhov, GK; Mishanina, ZG; Pavlov, VL, 1985) |
| "Prednisolone treatment normalized coagulopathies associated with chronic idiopathic hepatitis within one week in all 10 dogs that had coagulopathies at initial diagnosis." | 5.39 | A retrospective study of oral prednisolone treatment in canine chronic hepatitis. ( Favier, RP; Penning, LC; Poldervaart, JH; Rothuizen, J; van den Ingh, TS, 2013) |
| "To evaluate the effect of interferon and the benefit of prednisolone pretreatment in Oriental patients with chronic active hepatitis B, 120 male Chinese patients were randomly allocated to receive: 1) group A: a 4-week course of prednisolone followed by 2 weeks of no treatment and then a 12-week course of human lymphoblastoid interferon, 4 to 6 MU/m2 intramuscularly; 2) group B: as group A, but with placebo given instead of prednisolone; 3) group C: an 18-week course of placebo." | 5.07 | Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial. ( Chen, TJ; Chien, RN; Chu, CM; Liaw, YF; Lin, SM; Sheen, IS, 1994) |
| "Forty-one hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA positive Chinese patients with chronic active hepatitis B were randomized to receive either prednisolone or placebo oral for 8 weeks." | 5.07 | A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B. ( Lee, SD; Lin, HC; Lo, KJ; Tong, MJ; Tsai, YT; Wu, JC, 1991) |
| "The efficacy of human lymphoblastoid interferon (Wellferon) therapy was measured in 20 children with chronic hepatitis B with or without pretreatment with prednisolone." | 5.06 | Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon. ( Barigione, G; Cirillo, C; Facco, F; Giacchino, R; Giambartolomei, G; Navone, C; Terragna, A; Timitilli, A, 1988) |
| " Immunosuppressive treatment with initially 60mg/d prednisolone improved the skin condition but activated the chronic hepatitis, GPT rising up to 240 U/l." | 3.69 | [Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy]. ( Glück, T; Weber, P; Wiedmann, KH, 1994) |
| "Twenty patients with hepatitis B e antigen (HBeAg) -positive chronic hepatitis, who received 40 mg of prednisolone per day for three weeks followed by withdrawal, were studied for changes in alanine aminotransferase (ALT), triiodothyronine (T3), thyroxine (T4), and hepatitis B virus DNA polymerase (HBV-DNAp) levels determined before and during prednisolone treatment and after its withdrawal." | 3.68 | Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal. ( Itoh, S; Marutani, K; Matsuo, S; Oda, T; Sasaki, K, 1990) |
| " A 40-year-old Japanese woman with antiphospholipid syndrome has been treated with prednisolone for two years since she was diagnosed as having a mixed type of chronic active hepatitis and primary biliary cirrhosis." | 3.68 | Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report. ( Kaneko, S; Kawara, S; Kobayashi, K; Nakanuma, Y; Ogino, H; Saeki, R; Terasaki, S; Unoura, M; Wakabayashi, T, 1993) |
| "In 1981, we initiated combination therapy of short-term prednisolone withdrawal and adenine arabinoside (ARA-A) or interferon (IF) for the treatment of chronic hepatitis B." | 3.67 | Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study. ( Omata, M; Uchiumi, K, 1986) |
| "Changes in the host interferon system during short-term steroid hormone (prednisolone) withdrawal therapy in seven patients with HBeAg-positive chronic hepatitis B were investigated by estimating the in vitro interferon-alpha production in peripheral blood lymphocytes and 2-5 oligoadenylate synthetase activity in the serum." | 3.67 | Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy. ( Hashimoto, T; Hattori, N; Hinoue, Y; Hirai, N; Kobayashi, K; Morioka, T; Shimizu, M; Tanaka, N, 1988) |
| "Short-term prednisolone therapy was instituted on 27 patients with chronic active hepatitis (CAH) type B, in an attempt to induce seroconversion from hepatitis B e antigen (HBeAg) to the corresponding antibody (anti-HBe)." | 3.67 | Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. ( Ikeda, K; Kojima, M; Kumada, H; Mayumi, M; Seto, S; Suzuki, H; Tsukada, T; Yoshida, A, 1987) |
| " A marked increase in spontaneous and pokeweed mitogen-induced proliferation of IgG producing cells was observed in 30 patients with untreated autoimmune CAH when compared with 25 normal subjects and 21 patients with autoimmune disease in whom a remission had been induced and maintained by prednisolone (P less than 0." | 3.67 | IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function. ( Alexander, GJ; Eddleston, AL; Hegarty, JE; Nouri-Aria, KT; Williams, R, 1985) |
| "A patient with long-standing filarial chyluria developed severe lymphocytopenia, extensive mucosal candidiasis and disseminated cryptococcosis when given small doses of prednisolone and azathioprine, for the treatment of a co-existing chronic active hepatitis." | 3.66 | Filarial chyluria with opportunistic infections. ( Chandy, M; Date, A; Pulimood, BM, 1983) |
| "Six patients with histologically proven HBsAg-negative chronic active hepatitis (CAH), who were initially treated successfully with prednisolone with or without azathioprine, developed unacceptable adverse effects due to prednisolone." | 2.67 | D-penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effects. ( Callender, ME; McClements, BM, 1990) |
| "Sixty patients with chronic active hepatitis B and positive serum HBV-DNA were randomized into two treatment groups (n = 20, respectively) and one control group (no treatment; n = 20)." | 2.67 | Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. ( Heintges, T; Niederau, C; Niederau, M; Stremmel, W; Strohmeyer, G, 1992) |
| "Fifty-six patients with chronic active hepatitis (CAH) received immunosuppressive treatment (corticosteroids combined with azathioprine)." | 2.66 | HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis. ( Bessone, F; Fay, OH; Palazzi, J; Rojman, JA; Tanno, H, 1988) |
| "In 42 patients with chronic active hepatitis (CAH), liver biopsies were subjected to histological study and morphometry before and after prednisolone treatment (21 patients comprising group I) and treatment with a complex of vitamins B1, B6, B12 and C (21 patients comprising group II)." | 2.66 | [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens]. ( Mansurov, KhKh; Mirodzhov, GK; Mishanina, ZG; Pavlov, VL, 1985) |
| "Prednisolone peak levels were similar in the three groups." | 2.65 | Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects. ( Go, VL; Kluge, D; Uribe, M, 1984) |
| "Thirty-six patients with biopsy-proved chronic active hepatitis (CAH) were randomized." | 2.65 | Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study). ( Jávor, T; Kádas, I; Kerekes, E; Paál, M; Pár, A, 1983) |
| "Oral prednisolone was started and then tapered after achieving biochemical remission." | 1.56 | IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology. ( Enoki, Y; Hitomi, M; Inoue, N; Kawabata, H; Kawakatsu, Y; Minamikawa, T; Miyata, M; Motoi, S; Okazaki, Y; Sone, D; Ueda, Y; Yamaguchi, K, 2020) |
| "Liver fibrosis was not coarse, but delicate with severe activity in most patients showing chronic hepatitis defined by our strict criteria." | 1.48 | Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis. ( Fujiwara, K; Fukuda, Y; Kato, N; Nakano, M; Saito, M; Seza, K; Yasui, S; Yokosuka, O, 2018) |
| "A nationwide survey of autoimmune hepatitis (AIH) patients was performed in Japan in 2015." | 1.46 | Autoimmune hepatitis in Japan: trends in a nationwide survey. ( Abe, M; Arinaga-Hino, T; Fujisawa, T; Kang, JH; Nakamoto, N; Ohira, H; Suzuki, Y; Takahashi, A; Takaki, A; Takikawa, H; Tanaka, A; Torimura, T; Yonemoto, K; Yoshizawa, K; Zeniya, M, 2017) |
| "Prednisolone treatment normalized coagulopathies associated with chronic idiopathic hepatitis within one week in all 10 dogs that had coagulopathies at initial diagnosis." | 1.39 | A retrospective study of oral prednisolone treatment in canine chronic hepatitis. ( Favier, RP; Penning, LC; Poldervaart, JH; Rothuizen, J; van den Ingh, TS, 2013) |
| "Here we report two patients with severe juvenile dermatomyositis (JDM) complicated with extra musculocutaneous involvement." | 1.33 | Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement. ( Akalin, T; Aslan, MT; Gökben, S; Polat, M; Serdaroğlu, G; Tekgul, H; Tosun, A, 2006) |
| "We report here a patient with chronic active hepatitis who had no markers for hepatitis viruses and no hyper-gamma-globulinemia, but had high titers of antimitochondrial antibody." | 1.31 | A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia. ( Gershwin, ME; Mitamura, K; Morizane, T; Onozuka, Y; Shibata, M; Tanaka, A; Uchida, T, 2001) |
| "To determine whether "autoimmune hepatitis type IIb" should be categorized as a subgroup of autoimmune hepatitis, we conducted a clinicopathological study of 25 adult Japanese patients who were positive for anti-liver/kidney microsome-1 (anti-LKM-1) anti-body and infected with the hepatitis C virus (HCV)." | 1.30 | Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis. ( Abe, K; Fuzikawa, H; Hayashi, N; Kako, M; Kawaguchi, N; Kikuchi, K; Kitazawa, E; Kiyosawa, K; Komatsu, T; Miyakawa, H, 1997) |
| "The entity of autoimmune chronic active hepatitis is unclear, and perhaps it is better defined as steroid-responsive hepatitis." | 1.29 | Idiopathic chronic active hepatitis: a diagnostic and therapeutic dilemma. ( Al-Fadda, M; al-Kahtani, K; Ayub, A; Zafar, M, 1994) |
| "A 37 year old patient with chronic active hepatitis progressing to cirrhosis presented with increasing breathlessness and was found to be hypoxic with finger clubbing." | 1.29 | Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests. ( Dalton, HR; Fernando, SS; Joseph, A; Saunders, KB, 1994) |
| "A history of idiopathic thrombocytopenic purpura could be considered a contraindication for alpha-interferon therapy in patients with chronic viral hepatitis." | 1.29 | [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C]. ( Bacq, Y; Barin, F; Degenne, D; Fimbel, B; Gruel, Y; Metman, EH; Sapey, T, 1996) |
| "We report four cases of acute pneumonitis due either to interferon, or a herbal drug, "Sho-saiko-to", or both in combination, in patients with chronic active hepatitis, focusing on its pathogenesis and response to prednisolone therapy." | 1.29 | Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. ( Abe, Y; Ameshima, S; Ishizaki, T; Ito, S; Kitagawa, M; Kuriyama, M; Nakai, T; Sasaki, F; Shiozaki, K; Takahashi, H, 1996) |
| "The effectiveness of antiviral treatment on chronic hepatitis B, especially the priority of interferon with steroid withdrawal, was thought to be established through this study." | 1.28 | Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model. ( Imazeki, F; Ohto, M; Omata, M; Takano, S; Yokosuka, O, 1992) |
| "A 41 year old woman developed chronic active hepatitis with prominent cholestasis." | 1.28 | Ursodeoxycholic acid therapy in chronic active hepatitis. ( Bateson, MC, 1990) |
| "Prednisolone, 60 mg/day, was administered initially and the dose was tapered every 2 weeks over the 8 weeks period." | 1.28 | Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis. ( Chung, WK; Kim, HY; Park, CK; Shim, KS; Yoo, JY, 1989) |
| "Features typical of chronic active hepatitis were observed on examination of the liver biopsy, and both the clinical and histological pictures were unlike those of other possible causes of liver dysfunction, such as chronic rejection, cyclosporine hepatotoxicity, and non-A non-B chronic hepatitis." | 1.27 | Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting. ( Calne, R; Neuberger, J; Portmann, B; Williams, R, 1984) |
| "The term chronic active hepatitis covers aetiologically different conditions with similar histological features." | 1.27 | Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents. ( Mackay, IR, 1987) |
| "In primary biliary cirrhosis, drug-induced hepatitis, and non-hepatic immunological disorders, the production of the three autoantibodies did not directly correlate with liver cell damage." | 1.27 | Clinical evaluation of autoantibodies to liver cell membrane specific antigen, liver specific lipoprotein, and Tamm-Horsfall glycoprotein in autoimmune chronic active hepatitis. ( Arima, T; Morichika, S; Nagashima, H, 1987) |
| "Evidence for autoimmune chronic active hepatitis ab initio included prolonged fever, lymphadenopathy, urticaria, arthralgia, Coombs' positive hemolytic anemia, lymphopenia, a markedly raised level of immunoglobulin G and a positive antinuclear antibody test." | 1.27 | 'Acute' autoimmune hepatitis. ( Bhathal, PS; Crapper, RM; Frazer, IH; Mackay, IR, 1986) |
| "Five patients with autoimmune chronic active hepatitis were diagnosed for the first time over the age of 70 years." | 1.27 | Chronic active hepatitis in the elderly. ( Selby, CD; Toghill, PJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (49.48) | 18.7374 |
| 1990's | 39 (40.21) | 18.2507 |
| 2000's | 3 (3.09) | 29.6817 |
| 2010's | 4 (4.12) | 24.3611 |
| 2020's | 3 (3.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bayton, W | 1 |
| Watson, PJ | 1 |
| Bexfield, NH | 1 |
| Kawabata, H | 1 |
| Kawakatsu, Y | 1 |
| Inoue, N | 1 |
| Okazaki, Y | 1 |
| Sone, D | 1 |
| Yamaguchi, K | 1 |
| Ueda, Y | 1 |
| Hitomi, M | 1 |
| Miyata, M | 1 |
| Motoi, S | 1 |
| Enoki, Y | 1 |
| Minamikawa, T | 1 |
| Vuille-Lessard, É | 1 |
| Montani, M | 1 |
| Bosch, J | 1 |
| Semmo, N | 1 |
| Fujiwara, K | 1 |
| Fukuda, Y | 1 |
| Seza, K | 1 |
| Saito, M | 1 |
| Yasui, S | 1 |
| Nakano, M | 1 |
| Yokosuka, O | 2 |
| Kato, N | 1 |
| Favier, RP | 1 |
| Poldervaart, JH | 1 |
| van den Ingh, TS | 1 |
| Penning, LC | 1 |
| Rothuizen, J | 1 |
| Nagamura, N | 1 |
| Ueno, S | 1 |
| Fujishiro, H | 1 |
| Oonuma, H | 1 |
| Takahashi, A | 1 |
| Arinaga-Hino, T | 1 |
| Ohira, H | 1 |
| Torimura, T | 1 |
| Zeniya, M | 1 |
| Abe, M | 1 |
| Yoshizawa, K | 1 |
| Takaki, A | 1 |
| Suzuki, Y | 1 |
| Kang, JH | 1 |
| Nakamoto, N | 1 |
| Fujisawa, T | 1 |
| Yonemoto, K | 1 |
| Tanaka, A | 2 |
| Takikawa, H | 1 |
| GROS, H | 1 |
| IARTSEVA, AM | 1 |
| ZEREBTSOV, LA | 1 |
| ZHEREBTSOV, LA | 1 |
| MACKAY, IR | 3 |
| WEIDEN, S | 1 |
| UNGAR, B | 1 |
| MATVEEV, AA | 1 |
| LUPU, NG | 1 |
| POPESCU, IG | 1 |
| ZAMFIRESCU-GHEORGHIU, M | 1 |
| VELICAN, D | 1 |
| CIOBANU, F | 1 |
| Tosun, A | 1 |
| Serdaroğlu, G | 1 |
| Aslan, MT | 1 |
| Polat, M | 1 |
| Akalin, T | 1 |
| Tekgul, H | 1 |
| Gökben, S | 1 |
| Potthoff, A | 1 |
| Deterding, K | 1 |
| Trautwein, C | 1 |
| Flemming, P | 1 |
| Strassburg, CP | 1 |
| Manns, MP | 1 |
| Wedemeyer, H | 1 |
| Bahr, MJ | 1 |
| McFarlane, IG | 1 |
| Hegarty, JE | 3 |
| McSorley, CG | 1 |
| McFarlane, BM | 1 |
| Williams, R | 6 |
| Idrisova, RS | 1 |
| Tsoĭ, IG | 1 |
| Date, A | 1 |
| Chandy, M | 1 |
| Pulimood, BM | 1 |
| Neuberger, J | 1 |
| Portmann, B | 4 |
| Calne, R | 1 |
| Abonyi, M | 1 |
| Kisfaludy, S | 1 |
| Szalay, F | 1 |
| Uribe, M | 1 |
| Go, VL | 1 |
| Kluge, D | 1 |
| Kendrey, G | 1 |
| László, B | 1 |
| Pár, A | 2 |
| Paál, M | 1 |
| Kádas, I | 1 |
| Kerekes, E | 1 |
| Jávor, T | 1 |
| Vegnente, A | 1 |
| Larcher, VF | 1 |
| Mowat, AP | 2 |
| Thomas, HC | 1 |
| Brown, D | 1 |
| Labrooy, J | 1 |
| Epstein, O | 1 |
| Liaw, YF | 3 |
| Chu, CM | 3 |
| Su, IJ | 1 |
| Huang, MJ | 1 |
| Lin, DY | 1 |
| Chang-Chien, CS | 1 |
| Eisenburg, J | 1 |
| Schvarcz, R | 2 |
| Glaumann, H | 1 |
| Weiland, O | 1 |
| Jackson, LD | 1 |
| Song, E | 1 |
| Al-Fadda, M | 1 |
| Zafar, M | 1 |
| Ayub, A | 1 |
| al-Kahtani, K | 1 |
| Glück, T | 1 |
| Weber, P | 1 |
| Wiedmann, KH | 1 |
| Horsmans, Y | 1 |
| Piret, A | 1 |
| Brenard, R | 1 |
| Rahier, J | 1 |
| Geubel, AP | 1 |
| Lin, SM | 2 |
| Chen, TJ | 2 |
| Chien, RN | 1 |
| Sheen, IS | 2 |
| Saunders, KB | 1 |
| Fernando, SS | 1 |
| Dalton, HR | 1 |
| Joseph, A | 1 |
| Ben-Ari, Z | 1 |
| Dhillon, AP | 1 |
| Sherlock, S | 1 |
| Saeki, R | 1 |
| Kaneko, S | 1 |
| Terasaki, S | 1 |
| Unoura, M | 1 |
| Ogino, H | 1 |
| Wakabayashi, T | 1 |
| Kawara, S | 1 |
| Nakanuma, Y | 1 |
| Kobayashi, K | 2 |
| Payen, JL | 1 |
| Rabbia, I | 1 |
| Combis, M | 1 |
| Voigt, JJ | 1 |
| Vinel, P | 1 |
| Pascal, JP | 1 |
| Thiele, DL | 1 |
| DuCharme, L | 1 |
| Cunningham, MR | 1 |
| Mimms, LT | 1 |
| Cuthbert, JA | 1 |
| Lee, WM | 1 |
| Combes, B | 1 |
| Bacq, Y | 1 |
| Sapey, T | 1 |
| Gruel, Y | 1 |
| Fimbel, B | 1 |
| Degenne, D | 1 |
| Barin, F | 1 |
| Metman, EH | 1 |
| Nakajima, M | 1 |
| Kubota, Y | 1 |
| Miyashita, N | 1 |
| Niki, Y | 1 |
| Matsushima, T | 1 |
| Manabe, T | 1 |
| Murakami, C | 1 |
| Hino, K | 1 |
| Okazaki, M | 1 |
| Fujii, K | 1 |
| Okuda, M | 1 |
| Hanada, H | 1 |
| Yamasaki, T | 1 |
| Okita, K | 1 |
| Ishizaki, T | 1 |
| Sasaki, F | 1 |
| Ameshima, S | 1 |
| Shiozaki, K | 1 |
| Takahashi, H | 1 |
| Abe, Y | 1 |
| Ito, S | 1 |
| Kuriyama, M | 1 |
| Nakai, T | 1 |
| Kitagawa, M | 1 |
| Yamamoto, T | 1 |
| Yokoyama, A | 1 |
| Kamiyama, T | 1 |
| Nouchi, T | 1 |
| Kojima, S | 1 |
| Murata, N | 1 |
| Ikeda, T | 2 |
| Sato, C | 1 |
| Kanzler, S | 1 |
| Gerken, G | 1 |
| Dienes, HP | 1 |
| Meyer zum Büschenfelde, KH | 1 |
| Lohse, AW | 1 |
| Johnson, PJ | 1 |
| Miyakawa, H | 1 |
| Kitazawa, E | 1 |
| Abe, K | 1 |
| Kawaguchi, N | 1 |
| Fuzikawa, H | 1 |
| Kikuchi, K | 1 |
| Kako, M | 1 |
| Komatsu, T | 1 |
| Hayashi, N | 1 |
| Kiyosawa, K | 1 |
| Shibata, M | 1 |
| Morizane, T | 1 |
| Onozuka, Y | 1 |
| Uchida, T | 1 |
| Gershwin, ME | 1 |
| Mitamura, K | 1 |
| Niederau, C | 1 |
| Heintges, T | 1 |
| Niederau, M | 1 |
| Stremmel, W | 1 |
| Strohmeyer, G | 1 |
| Takano, S | 1 |
| Omata, M | 2 |
| Imazeki, F | 1 |
| Ohto, M | 2 |
| Lau, JY | 1 |
| Bird, GL | 1 |
| Gimson, AE | 1 |
| Alexander, GJ | 2 |
| de Man, RA | 1 |
| Berk, L | 1 |
| Schalm, SW | 1 |
| Stijnen, T | 1 |
| Podymova, SD | 1 |
| Fei, GZ | 1 |
| Sylvan, SP | 1 |
| Hellström, UB | 1 |
| Yao, GB | 1 |
| Ryss, EA | 1 |
| Fishzon-Ryss, IuI | 1 |
| Zargar, SA | 1 |
| Thapa, BR | 1 |
| Sahni, A | 1 |
| Mehta, S | 1 |
| Hayasaka, A | 1 |
| Kohen, H | 1 |
| Iida, S | 1 |
| Polus, M | 1 |
| Lee, SD | 1 |
| Tong, MJ | 1 |
| Wu, JC | 1 |
| Lin, HC | 1 |
| Tsai, YT | 1 |
| Lo, KJ | 1 |
| Egorov, VB | 1 |
| Gol'zand, IV | 1 |
| Bateson, MC | 1 |
| Heigl, F | 1 |
| Pape, GR | 1 |
| Bauriedel, G | 1 |
| Gerbig, H | 1 |
| Neudert, J | 1 |
| Zachoval, R | 1 |
| Wiebecke, B | 1 |
| Steinbeck, G | 1 |
| McClements, BM | 1 |
| Callender, ME | 1 |
| Itoh, S | 1 |
| Matsuo, S | 1 |
| Oda, T | 1 |
| Marutani, K | 1 |
| Sasaki, K | 1 |
| Uchiumi, K | 1 |
| Yamada, H | 1 |
| Shimizu, H | 1 |
| Taniguchi, O | 1 |
| Okumura, K | 1 |
| Yoo, JY | 1 |
| Kim, HY | 1 |
| Park, CK | 1 |
| Shim, KS | 1 |
| Chung, WK | 1 |
| Giacchino, R | 2 |
| Facco, F | 2 |
| Loy, A | 1 |
| Timitilli, A | 2 |
| Cirillo, C | 2 |
| Navone, C | 2 |
| Ciravegna, B | 1 |
| Pisani, N | 1 |
| Iwamoto, H | 1 |
| Tsuji, H | 1 |
| Fukui, N | 1 |
| Watanabe, H | 1 |
| Nunoi, K | 1 |
| Murai, K | 1 |
| Akagi, K | 1 |
| Fujishima, M | 1 |
| Yamada, T | 1 |
| Stellon, AJ | 2 |
| Uchihara, M | 1 |
| Daiguji, Y | 1 |
| Hasumura, Y | 1 |
| Takeuchi, J | 1 |
| Tanno, H | 1 |
| Fay, OH | 1 |
| Rojman, JA | 1 |
| Palazzi, J | 1 |
| Bessone, F | 1 |
| Sieber, G | 1 |
| Teichmann, JV | 1 |
| Möller, B | 1 |
| Hopf, U | 1 |
| Giambartolomei, G | 1 |
| Barigione, G | 1 |
| Terragna, A | 1 |
| Imamura, Y | 1 |
| Hashimoto, N | 1 |
| Umeda, N | 1 |
| Yamato, S | 1 |
| Morishita, K | 1 |
| Kojima, Y | 1 |
| Kawamura, N | 1 |
| Shoda, R | 1 |
| Matsueda, K | 1 |
| Shimojo, E | 1 |
| Webb, A | 1 |
| Compston, JE | 1 |
| Hirai, N | 1 |
| Shimizu, M | 2 |
| Morioka, T | 1 |
| Hinoue, Y | 1 |
| Tanaka, N | 1 |
| Hattori, N | 1 |
| Hashimoto, T | 1 |
| Dakkak, M | 1 |
| Bennett, JR | 1 |
| Tokita, H | 1 |
| Takahashi, Y | 1 |
| Tanaka, H | 1 |
| Yasuda, M | 1 |
| Kojima, M | 2 |
| Adachi, N | 1 |
| Yoshida, H | 1 |
| Mansurov, KhKh | 2 |
| Asfandiiarova, NS | 1 |
| Nikolaeva, OS | 1 |
| Mansurova, FKh | 1 |
| Rasunova, TKh | 1 |
| Morichika, S | 1 |
| Arima, T | 1 |
| Nagashima, H | 1 |
| Kumada, H | 1 |
| Ikeda, K | 1 |
| Yoshida, A | 1 |
| Seto, S | 1 |
| Tsukada, T | 1 |
| Suzuki, H | 1 |
| Mayumi, M | 1 |
| Thomas, PS | 1 |
| Crapper, RM | 1 |
| Bhathal, PS | 1 |
| Frazer, IH | 1 |
| Selby, CD | 1 |
| Toghill, PJ | 1 |
| Nouri-Aria, KT | 1 |
| Eddleston, AL | 1 |
| Mirodzhov, GK | 1 |
| Mishanina, ZG | 1 |
| Pavlov, VL | 1 |
| Wiese, M | 1 |
| Storch, W | 1 |
| Künzel, R | 1 |
| Trivedi, P | 1 |
| Cheeseman, P | 1 |
| Hegarty, J | 1 |
| Hoofnagle, JH | 1 |
| Davis, GL | 1 |
| Pappas, SC | 1 |
| Hanson, RG | 1 |
| Peters, M | 1 |
| Avigan, MI | 1 |
| Waggoner, JG | 1 |
| Jones, EA | 1 |
| Seeff, LB | 1 |
| Yamanishi, Y | 1 |
| Nosaka, Y | 1 |
| Kawasaki, H | 1 |
| Hirayama, C | 1 |
| Ikawa, S | 1 |
| de Maubeuge, J | 1 |
| Reding, P | 1 |
| Tielemans, C | 1 |
| Dratwa, M | 1 |
| Van Laethem, Y | 1 |
| Achten, G | 1 |
7 reviews available for prednisolone and Hepatitis, Chronic
| Article | Year |
|---|---|
T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment.
Topics: Antibodies, Monoclonal; Autoimmune Diseases; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surfac | 1982 |
Autoimmune hepatitis triggered by administration of an herbal medicine.
Topics: Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Drug Combinations; Drugs, Chinese Herba | 1997 |
[Chronic hepatitis C: virologic and immunologic aspects and questions of therapy].
Topics: Africa; Antiviral Agents; Asia; Europe; Genotype; Glucocorticoids; Hepacivirus; Hepatitis B Surface | 1997 |
Treatment of chronic viral hepatitis.
Topics: Acyclovir; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis, Chronic; Humans; Interferons; Prednisol | 1991 |
[Problem of chronic hepatitis (classification, pathogenesis and treatment].
Topics: Autoimmune Diseases; Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Hepatitis B Antibodies; | 1991 |
[Chronic hepatitis--various aspects of the problem].
Topics: Antiviral Agents; Azathioprine; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Hepatit | 1991 |
[Chronic active autoimmune hepatitis: literature review].
Topics: Autoantibodies; Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Hepatitis, Chronic; Hu | 1991 |
15 trials available for prednisolone and Hepatitis, Chronic
| Article | Year |
|---|---|
Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
Topics: Adult; Aged; Benzopyrans; Catechin; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis, | 1984 |
Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
Topics: Adult; Albumins; Bilirubin; Female; Hepatitis, Chronic; Humans; In Vitro Techniques; Kinetics; Male; | 1984 |
Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
Topics: Benzopyrans; Catechin; Drug Therapy, Combination; Hepatitis B; Hepatitis, Chronic; Humans; Liver Fun | 1983 |
Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial.
Topics: Adult; Alanine Transaminase; DNA, Viral; Drug Therapy, Combination; Ethnicity; Hepatitis B; Hepatiti | 1994 |
Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Topics: Adolescent; Adult; Aged; Aspartate Aminotransferases; DNA, Viral; Drug Therapy, Combination; Female; | 1992 |
Chronic posttransfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Chronic Disease; Female; Follow-Up Studies; Hepaciviru | 1991 |
A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
Topics: Adult; China; DNA, Viral; Double-Blind Method; Drug Administration Schedule; Female; Hematologic Tes | 1991 |
[Chronic active hepatitis B in children: effects of various methods of treatment].
Topics: Adjuvants, Immunologic; Child; Female; Hepatitis B; Hepatitis, Chronic; Humans; Immunologic Deficien | 1991 |
D-penicillamine therapy in patients with HBsAg-negative chronic active hepatitis and major prednisolone-induced adverse effects.
Topics: Adult; Aged; Azathioprine; Dose-Response Relationship, Drug; Female; Hepatitis B Surface Antigens; H | 1990 |
Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.
Topics: Adult; Aged; Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination; | 1985 |
Treatment of chronic type B hepatitis in Southeast Asia.
Topics: Asia, Southeastern; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis, Chronic; Humans; Immun | 1988 |
HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
Topics: Azathioprine; Clinical Trials as Topic; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; | 1988 |
Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Clinical Trials as Topic; Combined Modali | 1988 |
[Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens].
Topics: Ascorbic Acid; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; | 1985 |
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Alanine Transaminase; DNA-Directed DNA Polymerase; Double-Blind Method; Drug Administration S | 1986 |
75 other studies available for prednisolone and Hepatitis, Chronic
| Article | Year |
|---|---|
Prednisolone therapy for chronic hepatitis in English springer spaniels: a prospective study of 12 cases.
Topics: Animals; Dog Diseases; Dogs; Female; Hepatitis, Chronic; Male; Prednisolone; Prospective Studies; Tr | 2020 |
IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
Topics: Aged; Anti-Inflammatory Agents; Cholagogues and Choleretics; Hepatitis, Autoimmune; Hepatitis, Chron | 2020 |
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Aged; Autoantibodies; Azathioprine; Carcinoma, Transitional Cell; Causa | 2021 |
Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis.
Topics: Acute Disease; Antiviral Agents; Dexamethasone; Female; Follow-Up Studies; Hepatitis; Hepatitis, Aut | 2018 |
A retrospective study of oral prednisolone treatment in canine chronic hepatitis.
Topics: Animals; Dog Diseases; Dogs; Female; Hepatitis, Chronic; Male; Netherlands; Prednisolone; Retrospect | 2013 |
Hepatitis associated with hypereosinophilia suspected to be caused by HES that also presented with the pathological features of IgG4-related disease.
Topics: Alanine Transaminase; Alkaline Phosphatase; Antibodies, Antineutrophil Cytoplasmic; Aspartate Aminot | 2014 |
Autoimmune hepatitis in Japan: trends in a nationwide survey.
Topics: Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; D | 2017 |
[Critical comments on the glycocorticoid therapy of chronic hepatitis].
Topics: Hepatitis; Hepatitis A; Hepatitis, Chronic; Methylprednisolone; Prednisolone; Prednisone | 1963 |
[Chronic hepatitis as a result of Botkin's disease and prednisolone therapy].
Topics: Hepatitis; Hepatitis A; Hepatitis, Chronic; Humans; Liver Cirrhosis; Prednisolone | 1963 |
[Use of prednisolone in chronic hepatitis and liver cirrhosis].
Topics: Hepatitis; Hepatitis A; Hepatitis, Chronic; Humans; Liver Cirrhosis; Prednisolone | 1962 |
[COMPLICATIONS DURING PREDNISOLONE THERAPY OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS].
Topics: Adolescent; Adrenocortical Hyperfunction; Cardiovascular System; Dyspepsia; Geriatrics; Glycosuria; | 1963 |
TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE.
Topics: Adolescent; Anemia; Anemia, Pernicious; Antineoplastic Agents; Autoimmune Diseases; Azathioprine; Cl | 1964 |
[ON THE STUDY OF PATHOGENESIS OF RECURRENT EPIDEMIC HEPATITIS IN PATIENTS UNDERGOING HORMONE THERAPY].
Topics: Communicable Diseases; Drug Therapy; Hepatitis; Hepatitis A; Hepatitis, Chronic; Humans; Prednisolon | 1965 |
[Therapeutic investigations in experimental toxic chronic hepatitis].
Topics: Chemical and Drug Induced Liver Injury; Corrinoids; Cytochromes; Hepatitis; Hepatitis, Chronic; Pred | 1961 |
Severe juvenile dermatomyositis: two patients complicated with extra musculocutaneous involvement.
Topics: Adolescent; Child; Dermatomyositis; Hepatitis, Chronic; Humans; Lung; Lung Diseases, Interstitial; M | 2006 |
Steroid treatment for severe acute cryptogenic hepatitis.
Topics: Acute Disease; Adult; Female; Hepatitis, Chronic; Humans; Immunosuppressive Agents; Male; Mercaptopu | 2007 |
Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis.
Topics: Adolescent; Adult; Aged; Autoantibodies; Autoimmune Diseases; Azathioprine; Clinical Enzyme Tests; F | 1984 |
[Indicators of cellular immunity in various types of treatment of children with chronic hepatitis B].
Topics: Adjuvants, Immunologic; Adolescent; Child; Chronic Disease; Hepatitis B; Hepatitis, Chronic; Humans; | 1984 |
Filarial chyluria with opportunistic infections.
Topics: Azathioprine; Candidiasis; Chyle; Cryptococcosis; Filariasis; Hepatitis, Chronic; Humans; Lymphopeni | 1983 |
Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting.
Topics: Adult; Autoimmune Diseases; Azathioprine; Cyclosporins; Female; Hepatitis, Chronic; Humans; Liver Tr | 1984 |
[Chronic active giant cell hepatitis in a young adult].
Topics: Adolescent; Azathioprine; Hepatitis, Chronic; Humans; Liver; Male; Microscopy, Electron; Mitochondri | 1984 |
Duration of chronic active hepatitis and the development of cirrhosis.
Topics: Adolescent; Aspartate Aminotransferases; Autoantibodies; Azathioprine; Bilirubin; Child; Child, Pres | 1984 |
Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.
Topics: Adult; Alanine Transaminase; Antibody Formation; Azathioprine; Biopsy; Female; Hepatitis B; Hepatiti | 1983 |
[Interferon or C virus-induced autoimmune chronic hepatitis? Report of personal observations and review of the literature].
Topics: Adult; Autoantibodies; Biopsy; Chemical and Drug Induced Liver Injury, Chronic; Hepacivirus; Hepatit | 1994 |
Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis.
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Azathioprine; Biopsy; Drug Therapy, Combination; Femal | 1993 |
Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis.
Topics: Adolescent; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Resistance, Multiple; Hep | 1995 |
Idiopathic chronic active hepatitis: a diagnostic and therapeutic dilemma.
Topics: Autoimmune Diseases; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Hepatitis, Ch | 1994 |
[Hepatitis-B-associated vasculitis. Clinical course with glucocorticoid and alpha-interferon therapy].
Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Prednisolone; Vasculitis | 1994 |
Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report.
Topics: Autoimmune Diseases; Azathioprine; Drug Therapy, Combination; Female; Hepatitis, Chronic; Humans; Im | 1994 |
Spontaneous improvement in a patient with the hepatopulmonary syndrome assessed by serial exercise tests.
Topics: Adult; Azathioprine; Exercise Test; Hepatitis, Chronic; Humans; Hypoxia; Liver Cirrhosis; Lung Disea | 1994 |
Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis.
Topics: Actins; Adult; Alkaline Phosphatase; Antibodies, Antinuclear; Autoimmune Diseases; Bile Ducts, Intra | 1993 |
Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.
Topics: Adult; Antiphospholipid Syndrome; Female; Hepatitis, Chronic; Humans; Liver Cirrhosis, Biliary; Pred | 1993 |
[Disclosure of autoimmune hepatitis by interferon].
Topics: Adult; Autoimmune Diseases; Female; Hepatitis, Chronic; Humans; Interferon Type I; Prednisolone; Rec | 1993 |
Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Base | 1996 |
[Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C].
Topics: Adult; Antiviral Agents; Female; Glucocorticoids; Hepatitis C; Hepatitis, Chronic; Humans; Immunoglo | 1996 |
Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; Hepatitis C; Hepatitis, Chronic; Humans; Immunologic Fac | 1996 |
Hepatitis B virus carrier status linked to autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Autoantibodies; Autoimmune Diseases; Azathioprine; Biomarkers; Carrier | 1996 |
Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Drug Therapy, Combination; Drugs, | 1996 |
Hypergammaglobulinemic purpura associated with Sjögren's syndrome and chronic C type hepatitis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antinuclear; Cryoglobulins; Female; H | 1997 |
Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Dose-Respons | 1997 |
Treatment of autoimmune hepatitis.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Female; Hepatitis, Chronic; Humans; Imm | 1997 |
Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis.
Topics: Adult; Aged; Autoantibodies; Biopsy; Blotting, Western; Female; Fluorescent Antibody Technique, Indi | 1997 |
A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia.
Topics: Aged; Autoantibodies; Cholagogues and Choleretics; Female; gamma-Globulins; Glucocorticoids; Hepatit | 2001 |
Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model.
Topics: Antiviral Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Stu | 1992 |
Treatment of HBV reactivation after withdrawal of immunosuppression.
Topics: Chemical and Drug Induced Liver Injury, Chronic; Hepatitis B; Hepatitis B virus; Hepatitis, Chronic; | 1991 |
IgM anti-preS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B.
Topics: Adult; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Hepatitis B; Hepatitis B Antibo | 1991 |
Kayser-Fleischer like ring in autoimmune chronic active hepatitis.
Topics: Autoimmune Diseases; Child; Copper; Cornea; Diagnosis, Differential; Hepatitis, Chronic; Hepatolenti | 1991 |
[Cases of chronic hepatitis which showed clear changes of serum levels of 7S-collagen in response to steroid and interferon therapy].
Topics: Aged; Autoimmune Diseases; Chronic Disease; Collagen; Female; Hepatitis; Hepatitis B; Hepatitis, Chr | 1991 |
Ursodeoxycholic acid therapy in chronic active hepatitis.
Topics: Adult; Autoimmune Diseases; Azathioprine; Chronic Disease; Drug Therapy, Combination; Female; Hepati | 1990 |
[A 65-year old jaundiced patient with weight loss, fever and sicca syndrome].
Topics: Aged; Autoimmune Diseases; Biopsy; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver | 1990 |
Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chr | 1990 |
Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
Topics: Antiviral Agents; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; | 1986 |
Leu-1(CD5) B cell subpopulation in patients with various liver diseases--special reference to hepatitis B virus carrier and to changes caused by prednisolone therapy.
Topics: Adult; Aged; Antigens, Differentiation; B-Lymphocytes; Carrier State; CD5 Antigens; Female; Flow Cyt | 1988 |
Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis.
Topics: Adolescent; Adult; Biopsy; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surf | 1989 |
[Reactivation of virus replication during immunosuppressive therapy in children with chronic hepatitis B].
Topics: Azathioprine; Child; DNA Replication; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepat | 1989 |
[A case of mixed connective tissue disease associated with chronic active hepatitis].
Topics: Female; Hepatitis, Chronic; Humans; Middle Aged; Mixed Connective Tissue Disease; Prednisolone | 1989 |
Immunological mechanisms of corticosteroid therapy in chronic active hepatitis: analysis of peripheral blood suppressor T-cell and interleukin 2 activities.
Topics: Female; Hepatitis, Chronic; Humans; Immune Tolerance; In Vitro Techniques; Interleukin-2; Lymphocyte | 1988 |
Abnormalities of B cell activation and immunoregulation in patients with chronic inflammatory liver diseases.
Topics: Antibody Formation; Autoimmune Diseases; B-Lymphocytes; Cells, Cultured; Hemolytic Plaque Technique; | 1988 |
[A case of primary biliary cirrhosis-chronic active hepatitis overlapping syndrome with improved transaminase levels by steroid treatment].
Topics: Female; Hepatitis, Chronic; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prednisolone; Syndrome; T | 1988 |
Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
Topics: Adult; Aged; Bone and Bones; Bone Resorption; Female; Hepatitis, Chronic; Humans; Middle Aged; Osteo | 1988 |
Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy.
Topics: 2',5'-Oligoadenylate Synthetase; Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hep | 1988 |
Chronic active hepatitis.
Topics: Aged; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Humans; Prednisolone | 1988 |
[Back-ground factors which affect the outcome of steroid withdrawal therapy in patients with chronic type B hepatitis--statistical evaluation of the importance of the mode of HBV transmission].
Topics: Adolescent; Adult; Alanine Transaminase; Child; Female; Follow-Up Studies; Hepatitis B; Hepatitis B | 1987 |
[Immunocorrective therapy of patients with chronic active liver diseases of a viral nature].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Azathioprine; Female; Hepatitis B; Hepatitis, Chronic; Hu | 1987 |
Treatment of chronic active hepatitis and other liver diseases with corticosteroid agents.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Hepatitis, Alcoholic; Hepatitis, Chronic | 1987 |
Clinical evaluation of autoantibodies to liver cell membrane specific antigen, liver specific lipoprotein, and Tamm-Horsfall glycoprotein in autoimmune chronic active hepatitis.
Topics: Adult; Aged; Antigens, Surface; Autoantibodies; Autoantigens; Autoimmune Diseases; Enzyme-Linked Imm | 1987 |
Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; DNA-Directed DNA Polymerase; Female; Follo | 1987 |
Prednisolone causing amelioration of both vitiligo and chronic active hepatitis.
Topics: Hepatitis, Chronic; Humans; Male; Middle Aged; Prednisolone; Vitiligo | 1987 |
'Acute' autoimmune hepatitis.
Topics: Adult; Autoimmune Diseases; Female; Hepatitis, Chronic; Humans; Liver; Prednisolone; Time Factors | 1986 |
Chronic active hepatitis in the elderly.
Topics: Aged; Autoimmune Diseases; Azathioprine; Biopsy; Female; Hepatitis, Chronic; Humans; Male; Prednisol | 1986 |
IgG production in 'autoimmune' chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function.
Topics: Adult; Aged; Autoimmune Diseases; B-Lymphocytes; Cells, Cultured; Female; Hepatitis, Chronic; Humans | 1985 |
[Virus-associated chronic autoimmune aggressive hepatitis (HBsAg seronegative) with pronounced diarrhea].
Topics: Adolescent; Autoimmune Diseases; Azathioprine; Biopsy; Complement System Proteins; Diarrhea; Fluores | 1985 |
Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis.
Topics: Adolescent; Adult; Aged; Aging; Azathioprine; Child; Child, Preschool; Hepatitis, Chronic; Humans; I | 1985 |
Sterol and bile acid metabolism after short-term prednisolone treatment in patients with chronic active hepatitis.
Topics: Adolescent; Adult; Bile Acids and Salts; Cholesterol; Female; Hepatitis, Chronic; Humans; Male; Midd | 1985 |
[Cutaneous vasculitis associated with chronic hepatitis: 2 cases].
Topics: Azathioprine; Cryoglobulinemia; Female; Glomerulonephritis; Hepatitis, Chronic; Humans; Middle Aged; | 1985 |